Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

about

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention.

P2860

Q54937991-5FCBBCDC-B0F8-4821-95D8-2835789ADF13

P2860

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

Item

http://www.wikidata.org/entity/Q40987162

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

@en

type

Item

label

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

@en

prefLabel

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

@en

P1476

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

@en

P2093

Afshin Amirpour

http://www.w3.org/2001/XMLSchema#string

Ali Pourmoghadas

http://www.w3.org/2001/XMLSchema#string

Hamid Sanei

http://www.w3.org/2001/XMLSchema#string

Hooman Shariati

http://www.w3.org/2001/XMLSchema#string

Leila Salehizadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Random allocation software for parallel group randomized trials

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa

Drug-eluting stent: a review and update

Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.

Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting.

Panoptic total cardiovascular risk prediction using all predictors versus optimized risk assessment using variable subsets.

Clinical outcomes comparing eptifibatide and abciximab in ST elevation acute myocardial infarction patients undergoing percutaneous coronary interventions.

Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (I

P304

204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2277-9175.196831

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28217642

http://www.w3.org/2001/XMLSchema#string

P932

5220753

http://www.w3.org/2001/XMLSchema#string

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

about

P2860

P2860

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932